Protara Therapeutics Inc is trading at $4.13 (+5.9%) in after-hours trading as investors continue to react to visibility and attention surrounding the company's Annual General Meeting.
- The move extends a 6.9% rise from the June 12 regular session, with the stock successfully rebounding from recent multi-day weakness.
- While no new material fundamentals were disclosed during the meeting, the AGM has served as a catalyst for renewed investor interest and upward momentum.